DaVita
DVA
#2351
Rank
A$11.32 B
Marketcap
A$158.41
Share price
1.69%
Change (1 day)
-45.03%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): A$15.54

According to DaVita's latest financial reports the company's current EPS (TTM) is A$14.16. In 2024 the company made an earnings per share (EPS) of A$15.71 an increase over its 2023 EPS that were of A$10.84.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$15.54-1.1%
2024A$15.7144.94%
2023A$10.8427.26%
2022A$8.52-35.56%
2021A$13.2244.1%
2020A$9.1819.7%
2019A$7.66540.48%
2018A$1.20-76.07%
2017A$5.00-19.31%
2016A$6.20242.52%
2015A$1.81-62.87%
2014A$4.8713.43%
2013A$4.308.45%
2012A$3.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$30.42 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$14.60 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$20.94 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.71-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA